Docusign Inc. (NASDAQ:DOCU – Get Free Report) Director Teresa Briggs sold 364 shares of the business’s stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $44.31, for a total transaction of $16,128.84. Following the sale, the director directly owned 9,170 shares in the company, valued at $406,322.70. The trade was a 3.82% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
Docusign Stock Down 1.4%
Shares of NASDAQ DOCU traded down $0.65 on Friday, reaching $45.07. 18,041,867 shares of the company’s stock traded hands, compared to its average volume of 4,975,088. The business’s 50 day simple moving average is $56.58 and its two-hundred day simple moving average is $66.79. Docusign Inc. has a 12 month low of $40.16 and a 12 month high of $94.67. The company has a market cap of $9.03 billion, a price-to-earnings ratio of 31.52, a price-to-earnings-growth ratio of 1.89 and a beta of 1.00.
Wall Street Analyst Weigh In
DOCU has been the topic of several analyst reports. Piper Sandler dropped their target price on Docusign from $90.00 to $75.00 and set a “neutral” rating on the stock in a report on Friday, December 5th. Royal Bank Of Canada lowered their price target on Docusign from $95.00 to $70.00 and set a “sector perform” rating for the company in a research report on Monday, January 5th. Jefferies Financial Group cut shares of Docusign from a “buy” rating to a “hold” rating and dropped their price target for the stock from $105.00 to $45.00 in a research note on Monday. UBS Group cut their price objective on shares of Docusign from $85.00 to $75.00 and set a “neutral” rating on the stock in a research report on Friday, December 5th. Finally, JPMorgan Chase & Co. decreased their target price on shares of Docusign from $80.00 to $78.00 and set a “neutral” rating for the company in a report on Friday, December 5th. Five equities research analysts have rated the stock with a Buy rating and sixteen have assigned a Hold rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus target price of $78.80.
Hedge Funds Weigh In On Docusign
A number of hedge funds have recently bought and sold shares of DOCU. Centaurus Financial Inc. boosted its holdings in shares of Docusign by 2.6% during the 2nd quarter. Centaurus Financial Inc. now owns 5,398 shares of the company’s stock valued at $420,000 after acquiring an additional 136 shares during the last quarter. Mitchell & Pahl Private Wealth LLC lifted its position in Docusign by 0.7% during the third quarter. Mitchell & Pahl Private Wealth LLC now owns 21,422 shares of the company’s stock valued at $1,544,000 after purchasing an additional 149 shares during the period. Moors & Cabot Inc. boosted its holdings in Docusign by 5.7% in the second quarter. Moors & Cabot Inc. now owns 2,780 shares of the company’s stock worth $217,000 after purchasing an additional 150 shares during the last quarter. Savvy Advisors Inc. grew its position in Docusign by 5.4% in the 2nd quarter. Savvy Advisors Inc. now owns 3,090 shares of the company’s stock worth $241,000 after purchasing an additional 157 shares during the period. Finally, iA Global Asset Management Inc. grew its position in Docusign by 2.1% in the 2nd quarter. iA Global Asset Management Inc. now owns 7,872 shares of the company’s stock worth $613,000 after purchasing an additional 160 shares during the period. Hedge funds and other institutional investors own 77.64% of the company’s stock.
About Docusign
DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.
DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.
Featured Stories
- Five stocks we like better than Docusign
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- This makes me furious
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
